Month: November 2023

Academy Sports + Outdoors Reports Third Quarter 2023 Results

Third Quarter GAAP Diluted EPS of $1.31, or $1.38 Adjusted Diluted EPS Net Sales Decline (6.4)%; Comparable Sales Decline (8.0)% The Company Opened Five New Stores During the Third Quarter and a Total of 14 in 2023 New $600 Million Share Repurchase Program Announced KATY, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its financial results for the third quarter date ended October 28, 2023. “Our sales and net earnings for the third quarter came in below expectations, primarily driven by weakening consumer sentiment coupled with above normal temperatures that negatively impacted demand for Fall product. Over the past year we have seen customers change their shopping patterns and aggregate trips into the key shopping...

Continue reading

Financial targets and dividend policy of KH Group Plc

KH Group Plc Stock Exchange Release 30 November 2023 at 3:30 pm EET Financial targets and dividend policy of KH Group Plc As communicated at the Capital Markets Day, KH Group’s updated financial targets and dividend policy during the strategy change are as follows: Financial targetDuring the strategic change, KH Group’s balance sheet structure will change substantially. The target is to strengthen the balance sheet structure and reduce net debts through positive operative cash flow and divestments.   Dividend policyThe target for the next couple of financial years is to invest in core business and pay dividends after major divestments within the set guidelines from the balance sheet structure and financial contracts. Financial outlook for 2024The financial outlook for 2024 will be published together with the 2023 Financial Statements...

Continue reading

Ostin Technology Group Announces Major Product Upgrade to Pintura Photo Sharing Product

Nanjing, China, Nov. 30, 2023 (GLOBE NEWSWIRE) — Ostin Technology Group Co., Ltd. (the “Company”) (Nasdaq: OST), a supplier of display modules and polarizers in China, today announces new upgrade to its photo sharing product, Pintura. The new upgrades will elevate user experience with improvements to both Pintura’s hardware and software system. The Company plans to launch the upgraded Pintura product at the next Consumer Electronics Show (CES) in early 2024, which is also expected to be available for purchase through short-video platforms. Pintura product has recently undergone a remarkable and elegant transformation, unveiling a sleek new round-corner product design. In addition to its aesthetic upgrade, the new model is noticeably lighter than its predecessor, dropping from 4.6kg to 3.5kg. The new Pintura product standouts with...

Continue reading

Sacks Parente Golf, Inc. to Participate in the Benchmark Discovery One-on-One Investor Conference

CAMARILLO, CA, Nov. 30, 2023 (GLOBE NEWSWIRE) — Sacks Parente Golf, Inc. (Nasdaq: SPGC) (“SPG” or the “Company”), a technology-forward golf company with a growing portfolio of golf products, including putters, golf shafts, golf grips, and other golf-related accessories, announces that Chief Financial Officer Steve Handy will participate in the Benchmark Discovery One-on-One Investor Conference being held on December 7, 2023 at the New York Athletic Club in New York City. Investors that would like to schedule a one-on-one meeting with Mr. Handy to learn more about the Company’s innovative putters, new line of carbon fiber shafts, and vision for growth can submit their request online upon registering for the conference via this link. About Sacks Parente Golf Sacks Parente Golf, Inc. is a technology-forward golf company, with a growing...

Continue reading

Zymeworks Announces Participation in Upcoming Investor Conference

VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: 42nd Annual J.P. Morgan Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings on January 8-11, 2024 and a corporate presentation on January 11th, 2024 at 8:15 am Pacific Time. The presentation and webcast will be available on Zymeworks’ website at http://ir.zymeworks.com/events-and-presentations. About Zymeworks Inc. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful...

Continue reading

Dyadic Attends Investor Events in December

JUPITER, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following investor events during the month of December: NobleCon-19 December 3 – 5, 2023Florida Atlantic University, Boca Raton, FLMark Emalfarb, Chief Executive OfficerPresentation: Tuesday, December 5, 2023, 3:00 PM – 3:25 PM The Benchmark Company’s Investor ConferenceThursday, December 7, 2023The New York Athletic Club 180 Central...

Continue reading

Tremor International to Present at the Raymond James TMT and Consumer Conference

NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) — Tremor International Ltd. (AIM/NASDAQ: TRMR) (“Tremor” or the “Company”), a global leader in data-driven video and Connected TV (“CTV”) advertising technology offering a unified platform that enables advertisers to optimize campaigns and media companies to maximize inventory yield, announces it will participate in a fireside chat and host in-person investor meetings at the Raymond James TMT and Consumer Conference on Tuesday, December 5, 2023 in New York, NY. The fireside chat will be held at 2:15 PM ET on December 5, 2023 and will also be available on live webcast under the “Reports, Webcasts, Presentations & Circulars” section of Tremor’s investor relations website at https://investors.tremorinternational.com. For more information, or to schedule a meeting with management, please...

Continue reading

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

— Thought leader from top-ranked academic gynecology program to lead clinical and medical affairs at Femasys — ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the appointment of James Liu, M.D., as Chief Medical Officer. Dr. Liu joins Femasys as the company accelerates commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed®. “With an exciting product pipeline and a culture focused on execution of the development and commercialization of differentiated women’s health procedures,...

Continue reading

Clubhouse Media Group, Inc. Announces Model Brooklynne Bell Joins HoneyDrip.com

HoneyDrip Creator HoneyDrip Creator LOS ANGELES, Nov. 30, 2023 (GLOBE NEWSWIRE) — Clubhouse Media Group, Inc. (OTCMKTS: CMGR) (“Clubhouse Media Group”), a social media firm and digital agency, today announced that model and social media influencer, Brooklynne Bell, has joined HoneyDrip.com. Brooklynne has a large following, boasting 120K+ followers on Instagram alone. HoneyDrip.com is a digital platform designed and wholly owned by CMGR with a focus on the empowerment of creators. The site allows creators to connect and engage with fans and monetize exclusive content. “Brooklynne brings a certain level of class to the site, as we see from the majority of our creators,” said Alexandra Bolanos, Manager at HoneyDrip.com. “Allowing creators to join the site by invite-only, gives us the ability to review and approve...

Continue reading

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

New results from six patients with HGTa papillary tumors show five of six patients with HGRFS at Week 12 Data continue to support favorable tolerability of TARA-002 in patients with NMIBC As previously reported, anti-tumor activity observed in all three evaluable patients with CIS, including one heavily pre-treated BCG-unresponsive patient who achieved a complete response Company remains on track to report preliminary results from the expansion portion of the ADVANCED-1 trial in NMIBC patients with CIS in the first half of 2024 NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced additional encouraging data from the Phase 1a dose-escalation component of its ongoing ADVANCED-1...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.